Profile of Underdiagnosis Lung Cancer with Pulmonary Tuberculosis at Arifin Achmad General Hospital, Pekanbaru
Abstract
Background: Lung cancer and pulmonary tuberculosis are respiratory issues that collectively account for the world’s leading cause of mortality. Indonesia, being a nation endemic for Pulmonary Tuberculosis, frequently encounters instances of diagnosis overlap with lung cancer. Delays in the diagnosis of both pulmonary tuberculosis and lung cancer have a global impact on morbidity and mortality. Based on this, this study aims to determine the profile of Lung Cancer patients who were previously diagnosed as pulmonary tuberculosis as an initial diagnosis that can provide new criteria in establishing a diagnosis between pulmonary tuberculosis and lung cancer.
Method: This study is a descriptive cross-sectional study using total sampling collected over 1 year. The inclusion criteria were lung cancer patients previously diagnosed with clinical pulmonary tuberculosis, with or without anti-tuberculosis drugs obtained from medical record data. All results are presented in the form of a distribution table.
Results: Twenty seven patients diagnosed with adenocarcinoma, with the highest prevalence among males (77.78%). The duration of delay was less than 6 months (62.96%), being the highest rate in this study. Due to the delay in diagnosis, all patients diagnosed with lung cancer were at stage IV. Discussion: Adenocarcinoma is the most common form of lung cancer in men and individuals over 40 years old. Lung cancer with a latency duration of 6 months is typically diagnosed at stage IV. Clinical pulmonary tuberculosis must be investigated further if no clinical improvement is observed after one month of anti-tuberculosis drug treatment.
Conclusion: Diagnostic delays of lung cancer significantly impact patient survival. Screening for suspected lung cancer in clinical pulmonary tuberculosis is crucial to reduce morbidity and mortality. Sputum cytology and low-dose CT scan may be utilized as screening modalities.
Keywords
DOI: 10.33371/ijoc.v19i2.1293
Article Metrics
Abstract View: 548, 
PDF Download: 191
References
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209–49.
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424.
Chen GL, Guo L, Yang S, Ji DM. Cancer risk in tuberculosis patients in a high endemic area. BMC Cancer. 2021 Dec 1;21(1).
Laporan Kasus Tuberkulosis (TBC) Global dan Indonesia 2022 [Internet]. [cited 2024 Jul 10]. Available from: https://yki4tbc.org/laporan-kasus-tbc-global-dan-indonesia-2022/
Modern Method Of Differential Diagnosis Tuberculosis And Lung Cancer [Internet]. [cited 2023 Jul 11]. Available from: https://www.researchgate.net/publication/362652089_ MODERN_METHOD_OF_DIFFERENTIAL_DIAGNOSIS_TUBERCULOSIS_AND_LUNG_CANCER
Syahruddin E. Kanker paru : jenis karsinoma bukan sel kecil : pedoman nasional untuk diagnosis & penatalaksanaan di Indonesia 2018. Jakarta: UI Press; 2018. 237 p.
Isbaniah F, Burhan E, Sinaga BYM, Yanifitri DB, Handayani D, Harsini, et al. Pedoman Diagnosis Dan Penatalaksanaan Di Indonesia. Edisi Revisi 2. Cipinang Pulogadang Jakarta: PDPI; 2021. 3–6 p.
Aviani J, EH SM, Haryatie I, et al. The Delay in The Diagnosis of Lung Cancer Due to Misdiagnosis as Pulmonary Tuberculosis. Jurnal Respirologi Indonesia. 2017 Oct 17;37(4):288–92.
Cukic V. The Association Between Lung Carcinoma and Tuberculosis. Medical Archives. 2017;71(3):212.
Medscape Registration [Internet]. [cited 2024 Jul 14]. Available from: https://emedicine.medscape.com/article/230802-overview?form=fpf
What Is Lung Cancer? | CDC [Internet]. [cited 2024 Jul 19]. Available from: https://www.cdc.gov/cancer/lung/basic_info/what-is-lung-cancer.htm
Nastiti NP, Wulandari L, Sulistiawati S, et al. Prevalence of Lung Cancer with a History of Tuberculosis. Jurnal Respirasi. 2023 May 31;9(2):87–92.
Risnawati R, Pradjoko I, Wati FF. Nutrisi pada Penderita Kanker Paru. Jurnal Respirasi. 2020 Aug 26;5(3):91.
An SJ, Kim YJ, Han SS, Heo J. Effects of age on the association between pulmonary tuberculosis and lung cancer in a South Korean cohort. J Thorac Dis. 2020 Mar 1;12(3):375–82.
Ghoma Linguissi LS, Mabiala A. Pulmonary Tuberculosis and Lung Cancer: A Case Report. Journal of Internal Medicine Research & Reports. 2022 Jun 30;1–3.
Adegbite BR, Edoa JR, Achimi Agbo P, et al. Epidemiological, Mycobacteriological, and Clinical Characteristics of Smoking Pulmonary Tuberculosis Patients, in Lambaréné, Gabon: A Cross-Sectional Study. Am J Trop Med Hyg. 2020 Dec 2;103(6):2501–5.
World Health Organization (WHO). Indonesia [Internet]. Geneva; 2021 Mar [cited 2024 Jul 24]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/360-indonesia-fact-sheets.pdf
Jadhav U, Aurangabadkar GM, Upadhyay P, et al. A Case of Alveolar-Cell Carcinoma Misdiagnosed As Tubercular Bronchopneumonia. Cureus. 2022 Nov 11;
Oh CM, Roh YH, Lim D, et al. Pulmonary Tuberculosis is Associated with Elevated Risk of Lung cancer in Korea: The Nationwide Cohort Study. J Cancer. 2020;11(7):1899–906.
What Are the Risk Factors for Lung Cancer? | CDC [Internet]. [cited 2024 Jul 27]. Available from: https://www.cdc.gov/cancer/lung/basic_info/risk_factors.htm
Masamba LPL, Jere Y, Brown ERS, Gorman DR. Tuberculosis Diagnosis Delaying Treatment of Cancer: Experience From a New Oncology Unit in Blantyre, Malawi. J Glob Oncol. 2016 Feb;2(1):26–9.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Email this article 
